Clinical Trials Browser

Phase 2 × Lung Neoplasms × Tetracycline × Clear all

NCT01880515 2025-05-11

Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)

Phase 2 Completed

107 enrolled 8 charts

Exanthema, Lung Neoplasms